Authors:
LAURENCET FM
DOUCET A
LYDIATE V
JACQUIER MC
MERMILLOD B
ANDERSEN S
CHAPUIS B
Citation: Fm. Laurencet et al., QUALITY EVALUATION OF PLATELETPHERESIS USING THE NEW AMICUS (BAXTER) CELL SEPARATOR - EVOLUTION OF CD-62 EXPRESSION, Journal of clinical apheresis, 13(2), 1998, pp. 47-55
Authors:
MIRIMANOFF RO
MORO D
BOLLA M
MICHEL G
BRAMBILLA C
MERMILLOD B
MIRALBELL R
ALBERTO P
Citation: Ro. Mirimanoff et al., ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY FOR INOPERABLE STAGE-III NON-SMALL-CELL LUNG-CANCER - LONG-TERM RESULTS OF 2 PHASE-II GOTHA TRIALS, International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 487-494
Authors:
HOSLI P
BONNEFOI H
MIRIMANOFF RO
MERMILLOD B
ALBERTO P
Citation: P. Hosli et al., EFFECT OF LOW-DOSE CHEST IRRADIATION BEFORE CHEMOTHERAPY ON THE RATE OF LOCAL FAILURE IN SMALL-CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 41(2), 1998, pp. 287-289
Authors:
EXTERMANN P
BISCHOF P
MARGUERAT P
MERMILLOD B
Citation: P. Extermann et al., 2ND-TRIMESTER MATERNAL SERUM SCREENING FOR DOWNS-SYNDROME - FREE BETA-HUMAN CHORIONIC-GONADOTROPIN (HCG) AND ALPHA-FETOPROTEIN, WITH OR WITHOUT UNCONJUGATED ESTRIOL, COMPARED WITH TOTAL HCG, ALPHA-FETOPROTEIN AND UNCONJUGATED ESTRIOL, Human reproduction, 13(1), 1998, pp. 220-223
Citation: O. Irion et al., A RANDOMIZED TRIAL COMPARING VAGINAL AND CERVICAL PROSTAGLANDIN GEL FOR CERVICAL RIPENING AND LABOR INDUCTION, Obstetrics and gynecology, 91(1), 1998, pp. 65-71
Authors:
LAURENCET FM
ZULIAN GB
BAUER J
MERMILLOD B
ITEN PA
ALBERTO P
Citation: Fm. Laurencet et al., FEASIBILITY, TOXICITY, AND ACTIVITY OF LNH84-DERIVED CHEMOTHERAPY IN THE MANAGEMENT OF AGGRESSIVE LYMPHOMAS, American journal of hematology, 55(4), 1997, pp. 199-204
Authors:
ALLAL AS
MERMILLOD B
ROTH AD
MARTI MC
KURTZ JM
Citation: As. Allal et al., IMPACT OF CLINICAL AND THERAPEUTIC FACTORS ON MAJOR LATE COMPLICATIONS AFTER RADIOTHERAPY WITH OR WITHOUT CONCOMITANT CHEMOTHERAPY FOR ANALCARCINOMA, International journal of radiation oncology, biology, physics, 39(5), 1997, pp. 1099-1105
Authors:
GUERNE PA
SALVI M
SEITZ M
BRUHLMANN P
RIVIER G
FREY D
MERMILLOD B
VISCHER TL
TIERCY JM
ARROYO J
BAS S
GABAY C
GERBER N
GERSTER JC
SO A
OTT H
VANLINTHOUDT D
SAXER M
TYNDALL A
Citation: Pa. Guerne et al., MOLECULAR ANALYSIS OF HLA-DR POLYMORPHISM IN POLYMYALGIA-RHEUMATICA, Journal of rheumatology, 24(4), 1997, pp. 671-676
Authors:
SCHMIDLIN F
DELACRETAZ G
OSWALD M
ISELIN C
JICHLINSKI P
MERMILLOD B
LEMOINE R
LEISINGER HJ
GRABER P
Citation: F. Schmidlin et al., ENHANCEMENT OF TISSUE LESION DEPTH BY DUAL-WAVELENGTH IRRADIATION WITH THE ND-YAG KTP LASER - PERSPECTIVES FOR LASER PROSTATECTOMY/, Lasers in medical science, 12(4), 1997, pp. 364-370
Authors:
FOURNIER PE
STALDER J
MERMILLOD B
CHANTRAINE A
Citation: Pe. Fournier et al., EFFECTS OF A 110 KILOMETERS ULTRA-MARATHON RACE ON PLASMA-HORMONE LEVELS, International journal of sports medicine, 18(4), 1997, pp. 252-256
Citation: C. Depree et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN AS ADJUVANT TREATMENT FOR AUTOLOGOUSBLOOD DONATION IN ELECTIVE SURGERY WITH LARGE BLOOD NEEDS (GREATER-THAN-OR-EQUAL-TO-5 UNITS) - A RANDOMIZED STUDY, Transfusion, 37(7), 1997, pp. 708-714
Authors:
ALLAL AS
MERMILLOD B
ROTH AD
MARTI MC
KURTZ JM
Citation: As. Allal et al., THE IMPACT OF TREATMENT FACTORS ON LOCAL-CONTROL IN T2-T3 ANAL CARCINOMAS TREATED BY RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY, Cancer, 79(12), 1997, pp. 2329-2335
Authors:
ROBERT JH
AMBROGI V
MERMILLOD B
DAHABREH D
GOLDSTRAW P
Citation: Jh. Robert et al., FACTORS INFLUENCING LONG-TERM SURVIVAL AFTER LUNG METASTASECTOMY, The Annals of thoracic surgery, 63(3), 1997, pp. 777-784
Authors:
ZIMMERMANN M
SENTICI A
ADAMEC R
METZGER J
MERMILLOD B
RUTISHAUSER W
Citation: M. Zimmermann et al., LONG-TERM PROGNOSTIC-SIGNIFICANCE OF VENTRICULAR LATE POTENTIALS AFTER A FIRST ACUTE MYOCARDIAL-INFARCTION, The American heart journal, 134(6), 1997, pp. 1019-1028
Authors:
SAUDANKISTER A
GABAY C
TIERCY JM
MERMILLOD B
GUERNE PA
VISCHER TL
Citation: A. Saudankister et al., ADULT SERONEGATIVE ARTHRITIS WITH ANTINUCLEAR ANTIBODIES - A DISTINCTGROUP OF PATIENTS WITH A DIFFERENT IMMUNOGENETIC PATTERN FROM SEROPOSITIVE RHEUMATOID-ARTHRITIS AND A GOOD OUTCOME, Revue du rhumatisme, 63(5), 1996, pp. 313-320
Authors:
SCHURCH MA
RIZZOLI R
MERMILLOD B
VASEY H
MICHEL JP
BONJOUR JP
Citation: Ma. Schurch et al., A PROSPECTIVE-STUDY ON SOCIOECONOMIC ASPECTS OF FRACTURE OF THE PROXIMAL FEMUR, Journal of bone and mineral research, 11(12), 1996, pp. 1935-1942
Authors:
MIRALBELL R
BIERI S
MERMILLOD B
HELG C
SANCHO G
PASTOORS B
KELLER A
KURTZ JM
CHAPUIS B
Citation: R. Miralbell et al., RENAL TOXICITY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - THE COMBINED EFFECTS OF TOTAL-BODY IRRADIATION AND GRAFT-VERSUS-HOST DISEASE, Journal of clinical oncology, 14(2), 1996, pp. 579-585
Authors:
PAQUAY JL
ZIMMERMANN M
MERMILLOD B
ADAMEC R
Citation: Jl. Paquay et al., IMMEDIATE AND DAY-TO-DAY REPRODUCIBILITY OF THE SIGNAL-AVERAGED ELECTROCARDIOGRAM IN PATIENTS WITH CORONARY-ARTERY DISEASE, PACE, 19(4), 1996, pp. 443-454
Authors:
LAURENCET FM
ZULIAN GB
DIETRICH PY
ANCHISI S
MERMILLOD B
ALBERTO P
Citation: Fm. Laurencet et al., TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMP HOMA - THE EXPERIENCE OF A GENERAL-HOSPITAL, Bulletin du cancer, 83(10), 1996, pp. 864-869
Citation: P. Beris et al., EFFECT OF ERYTHROPOIETIN DURING PREDONATION OF 5 UNITS OF BLOOD BY PATIENTS AS CANDIDATES FOR SURGERY WITH INCREASED TRANSFUSION REQUIREMENTS - A RANDOMIZED STUDY, British Journal of Anaesthesia, 76, 1996, pp. 195-195
Authors:
CHALANDON Y
ROUXLOMBARD P
MERMILLOD B
BERIS P
CHAPUIS B
DOUCET A
DAYER JM
Citation: Y. Chalandon et al., SINGLE-DONOR PLATELET APHERESIS - BENEFIT OF LEUKOCYTES PRESTORAGE FILTRATION OVER POST-STORAGE (BEDSIDE) DELEUKOCYTATION, Blood, 88(10), 1996, pp. 1324-1324
Authors:
TERRIER F
TOURNIAIRE J
BELENGER J
SLOSMAN D
RUBBIA L
GROSSHOLZ M
MENTHA G
HILTBRAND E
MERMILLOD B
Citation: F. Terrier et al., MAGNETIC-RESONANCE-IMAGING WITH SUPERPARAMAGNETIC IRON-OXIDE PARTICLES TO EVALUATE HEPATIC MACROPHAGE-MONOCYTIC PHAGOCYTOSIS AFTER ARTERIALDEVASCULARIZATION IN MINIPIGS, Academic radiology, 2(7), 1995, pp. 565-575
Citation: Gb. Zulian et al., VINCRISTINE, ETOPOSIDE, MITOXANTRONE AND PREDNISONE (VEMP) AS FIRST-LINE CHEMOTHERAPY FOR HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 805-805